tiprankstipranks

Kaveri Pohlman Profile - BTIG Analyst

18 Followers
tipranks
Kaveri Pohlman

Kaveri Pohlman
BTIG

Wall Street Analyst
#8,504 out of 8,627 Wall Street Analysts
#35,150 out of 36,479 experts

Success Rate

23%
26 out of 115 ratings made a profit

Average Return

-26.20%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Kaveri Pohlman's trades since 2022 and holding each position for 1 Year would result in 22.61% of your transactions generating a profit, with an average return of -26.2% per rating.

Stock Rating Distribution

176Ratings
84.09% Buy
15.91% Hold
0.00% Sell
Distribution of Kaveri Pohlman's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Checkmate Pharmaceuticals, Inc.
(CMPI)
Rating:Buy
Date:Apr 11, 2022 - Apr 19, 2022
Return:+269.60%
The most profitable rating made by Kaveri Pohlman

Kaveri Pohlman's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
CMPI
Checkmate Pharmaceuticals
Apr 19, 2022
Hold
Downgraded
4Ratings
100%
+214.80%
CytomX Therapeutics
Jul 06, 2022
Buy
Assigned
$8.00
(444.22% Upside)
3Ratings
0%
-56.13%
OncoSec Medical
Nov 23, 2022
Hold
Downgraded
6Ratings
0%
-80.58%
Oncternal Therapeutics
May 05, 2023
Hold
Assigned
4Ratings
0%
-68.17%
Sonnet BioTherapeutics Holdings
Aug 14, 2023
Buy
Assigned
$2.00
(28.21% Upside)
6Ratings
0%
-81.85%
NexImmune
Sep 01, 2023
Hold
Assigned
3Ratings
0%
-83.60%
G1 Therapeutics
Oct 13, 2023
Hold
Assigned
11Ratings
0%
-51.55%
Seagen
Nov 01, 2023
Hold
Assigned
12Ratings
0.00%
Nuvation Bio
Nov 02, 2023
Hold
Reiterated
8Ratings
0%
-65.27%
MacroGenics
Nov 06, 2023
Buy
Assigned
$12.00
(37.77% Upside)
11Ratings
55%
+3.62%
List of latest recommendations made by Kaveri Pohlman. Click to expand and see Kaveri Pohlman's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Kaveri Pohlman activity FAQ

What is the performance of Kaveri Pohlman's recommendations?
The percentage of profitable recommendations made by Kaveri Pohlman is 23%, and the average return per transaction is -26.20%.
    What stocks does Kaveri Pohlman cover?
    Kaveri Pohlman mostly covers RCUS , MRSN , BCAB stocks.
      What was Kaveri Pohlman’s latest rating?
      Kaveri Pohlman latest rating was a buy on AMAM with a price target of $26.00, which represents an Upside of 94.90%
        What was Kaveri Pohlman's most profitable rating?
        Kaveri Pohlman’s most profitable ratings was a buy on CMPI stock on Apr 11, 2022 - Apr 19, 2022. The return on the trade was +269.60%.
          Where can I see a list of stock analyst ratings?
          You can see a list of daily stock analyst ratings here.
            What are the most recommended stocks by analysts?
            You can see a list of the most recommended stocks by analysts here